References
Kurzynski TA, Yrios YW, Helstad AC, Field CR: Aerobically incubated thioglycolate broth disk method for antibiotic susceptibility testing of anaerobes. Antimicrobial Agents and Chemotherapy 1976, 10: 727–732.
National Committee for Clinical Laboratory Standards: Tentative standard, M11-T2. Methods for antimicrobial susceptibility testing of anaerobic bacteria. NCCLS, Villanova, PA, 1989.
Zabransky RJ, Birk RJ, Kurzynski TA, Toohey KL: Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure. Journal of Clinical Microbiology 1986, 24: 181–185.
Aldridge KE, Henderberg A, Schiro DD, Sanders CV: Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates. Journal of Clinical Microbiology 1990, 28: 375–378.
Barry AL, Packer RR: Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method. Journal of Clinical Microbiology 1984, 20: 912–916.
Barry AL, Jones RN, The Collaborative Antimicrobial Susceptibility Testing Group: Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines. Journal of Clinical Microbiology 1988, 26: 776–777.
Jones RN, Barry AL, Fuchs PC, Allen SD: Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure. Diagnostic Microbiology and Infectious Diseases 1987, 8: 87–94.
Jorgensen JH, Redding CS, Howell AW: Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the new b-lactam antibiotics. Journal of Clinical Microbiology 1986, 23: 545–550.
Amsterdam D, Jones R: Antimicrobic Newsletter 1988, 5: 41–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barry, A.L. Anaerobic susceptibility tests with single breakpoint concentrations. Eur. J. Clin. Microbiol. Infect. Dis. 9, 849–850 (1990). https://doi.org/10.1007/BF01967391
Issue Date:
DOI: https://doi.org/10.1007/BF01967391